tiprankstipranks

Portfolio #1 - New Portfolio

Portfolio #1
Individual Investor
Ranked #425,522 out of 781,107 TipRanks' Investors
Success Rate
32%
178 out of 554
profitable transactions
Average Return
20.54%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 3.39%
6-Month Return▼ 0.06%
12-Month Return▲ 24.57%
YTD Return▲ 1.83%
Total Return▲ 169.18%

Best Trade

Opened at
Closed at-
Gain▲ 5216.99%

Bio

General portfolio. I have a private one which I am more active in

Performance

26.04%0-26.04%
▲ 9.79%
▲ 3.53%
▼ 2.29%
Jun 2024
▲ 8.13%
▲ 1.21%
▲ 5.78%
Jul 2024
▼ 13.14%
▲ 2.34%
▼ 2.28%
Aug 2024
▲ 2.93%
▲ 2.10%
▲ 1.28%
Sep 2024
▲ 10.00%
▼ 0.89%
▲ 0.42%
Oct 2024
▲ 26.04%
▲ 5.96%
▲ 3.36%
Nov 2024
▲ 5.93%
▼ 2.41%
▼ 5.85%
Dec 2024
▲ 7.55%
▲ 1.96%
▲ 1.83%
Jan 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 9.79%▲ 3.53%▼ 2.29%
▲ 8.13%▲ 1.21%▲ 5.78%
▼ 13.14%▲ 2.34%▼ 2.28%
▲ 2.93%▲ 2.10%▲ 1.28%
▲ 10.00%▼ 0.89%▲ 0.42%
▲ 26.04%▲ 5.96%▲ 3.36%
▲ 5.93%▼ 2.41%▼ 5.85%
▲ 7.55%▲ 1.96%▲ 1.83%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
VBI Vaccines
▼ 99.99%
2
Close
Jan 13, 2025
Fission Uranium
▲ 7.23%
2
Close
Dec 24, 2024
Paladin Energy Ltd
0.01%
▲ 14.26%
1
Open
Dec 24, 2024
Bellerophon
▼ 71.88%
4
Close
Dec 18, 2024
TFF Pharmaceuticals
▼ 99.96%
2
Close
Dec 12, 2024
Atlantica Sustainable Infrastructure
▼ 29.11%
2
Close
Dec 11, 2024
TRACON Pharmaceuticals
▼ 100.00%
2
Close
Dec 02, 2024
Oncternal Therapeutics
▼ 98.02%
2
Close
Dec 02, 2024
Olema Pharmaceuticals
0%
▼ 44.07%
1
Open
Nov 29, 2024
Vaxart
0%
▲ 17.46%
1
Open
Nov 14, 2024
Celularity
0%
▼ 35.21%
1
Open
Nov 08, 2024
Blackrock Health Sciences Trust II
0%
▲ 0.89%
1
Open
Oct 17, 2024
D-Wave Quantum
0%
▲ 406.73%
1
Open
Oct 17, 2024
Guidewire
0%
▼ 6.20%
1
Open
Oct 16, 2024
Vistra Energy
0%
▲ 26.12%
1
Open
Oct 16, 2024
Enlivex
0%
▼ 33.14%
1
Open
Oct 16, 2024
Oklo Inc
0.21%
▲ 123.61%
1
Open
Oct 15, 2024
TransCode Therapeutics
0.02%
▼ 86.26%
1
Open
Oct 15, 2024
Eiger Biopharmaceuticals
▼ 96.66%
2
Close
Oct 01, 2024
Phasebio Pharmaceuticals
▼ 99.36%
2
Close
Oct 01, 2024